
Cambridge Major Laboratories' US Development Headquarters is housed in a state-of-the-art 60,000 square foot GMP facility. The site has all of the capabilities required to provide API development and API manufacturing services from early pre-clinical to post-NDA commercial production. The facility has a wide range of technologies including plant scale hydrogenation and cryogenics (-90C).
General features of the US Development Facility are as follows:
The facility incorporates all of the latest technologies for HVAC and Process control. The HVAC systems are controlled by a Building Automation System (BAS) which monitors the temperature, pressures and humidity of the processing areas (labs and plant). Each processing area contains its own Air Handling Unit with once-through air.
Resources
From Discovery through commercial manufacture of active pharmaceutical ingredients – We Deliver